Pfizer completes acquisition of Medivation

As of midnight last night, Pfizer completed the acquisition of Medivation and therefore enzalutamide (Xtandi) is now being sold in the USA by Pfizer and Astellas and by Astellas in the rest of the world. For the details, see here.

A “shopping war” for Medivation?

It appears that the major pharma companies have initiated yet another merger frenzy, with at least two companies expressing interest in acquiring Medivation (the company that developed enzalutamide/Xtandi). … READ MORE …